AIM ImmunoTech (AIM) Stock Price, Quote, News & History | Benzinga

AIM ImmunoTech Inc (AIM) Stock Price, Quote, News & History

AIMAMEX

Trade with Public

Trade with Public

$0.4000

-0.006-1.48%

At close: Jun 17, 5:00 PM EST

$0.3842

-0.0158-3.95%

After Hours: 7:57 PM EST

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.39

Close

$0.40

Volume / Avg.

2.03M / 29.25M

Day Range

$0.38 - $0.40

52 Wk Range

0.21 - 20.33

Market Cap

$10.36M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

26.16%

Days to Cover

1

Recent AIM ImmunoTech Inc News

What's Going On With AIM ImmunoTech Stock Friday?

AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.

Akanksha Bakshi

Why Is AIM ImmunoTech Stock Gaining Today?

AIM ImmunoTech stock surges after Japan fully approved a patent covering Ampligen with checkpoint inhibitors, strengthening its cancer-treatment IP portfolio.

Nabaparna Bhattacharya

Why Is Micro-Cap AIM ImmunoTech Stock Surging?

AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer patients.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-11.32M

Investing Cash Flow (TTM)

918.00K

Financing Cash Flow (TTM)

15.32M

Free Cash Flow (TTM)

-11.67M

Capital Expenditure (TTM)

-357.00K

Net Change in Cash (TTM)

4.92M

Analyst Trends and Forecast

1

Apr

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.48M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.93

PB Ratio (TTM)

5.15

Earnings Yield % (TTM)

-1061.58%

Earnings Yield % (FWD)

-301.72%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.08

Company Debt

Total Debt

$4.21M

LT Debt

$210.00K

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$860.00K

Total Cash

$5.82M

Debt to Equity

2.15

Issuance of Debt (TTM)

$1.89M

Repayment of Debt (TTM)

-$860.00K

Key Statistics

Open

$0.39

Close

$0.40

Volume / Avg.

2.03M / 29.25M

Day Range

$0.38 - $0.40

52 Wk Range

0.21 - 20.33

Market Cap

$10.36M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

45

Short Interest

26.16%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy AIM ImmunoTech (AIM) stock?

A

You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AIM ImmunoTech (AIM) competitors?

A

There are no as such competitors for AIM ImmunoTech.

Q

What is the forecast, or price target, for AIM ImmunoTech (AIM) stock?

A

AIM ImmunoTech has a consensus price target of $5.00.

Q

What is the current price for AIM ImmunoTech (AIM)?

A

The stock price for AIM ImmunoTech (AMEX: AIM) is $0.3842 last updated June 17, 2026 at 7:57 PM EDT.

Q

Does AIM ImmunoTech (AIM) pay a dividend?

A

There are no upcoming dividends for AIM ImmunoTech.

Q

When is AIM ImmunoTech (AMEX:AIM) reporting earnings?

A

AIM ImmunoTech does not have any upcoming earnings scheduled.

Q

Is AIM ImmunoTech (AIM) going to split?

A

There is no upcoming split for AIM ImmunoTech.

Q

What sector and industry does AIM ImmunoTech (AIM) operate in?

A

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.